Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review
Background: Tuberculosis, like COVID-19, is most often a pulmonary disease. The COVID-19 pandemic has severely disrupted tuberculosis services in myriad ways: health facility closures, lockdowns, travel bans, overwhelmed healthcare systems, restricted export of antituberculous drugs, etc. The effect...
Main Authors: | Tulip A. Jhaveri, Celia Fung, Allison N. LaHood, Andrew Lindeborg, Chengbo Zeng, Rifat Rahman, Paul A. Bain, Gustavo E. Velásquez, Carole D. Mitnick |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/19/5656 |
Similar Items
-
The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study
by: Adam Nowiński, et al.
Published: (2023-09-01) -
Characteristics of subclinical tuberculosis compared to active symptomatic tuberculosis using nationwide registry cohort in Korea: prospective cohort study
by: Yun-Jeong Jeong, et al.
Published: (2023-12-01) -
Association of Underlying Comorbidities and Sites of tuberculosis: an analysis using surveillance data
by: Yun-Jeong Jeong, et al.
Published: (2022-11-01) -
Hospitalizations for tuberculosis in Sicily over the years 2009–2021: Clinical features, comorbidities, and predictors of mortality
by: Luca Pipitò, et al.
Published: (2023-09-01) -
Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis
by: Edinson Dante Meregildo-Rodriguez, et al.
Published: (2024-01-01)